Hengrui Pharmaceutical: the application for marketing license of Emacetinib Sulfate tablets is accepted.

Faifei News Agency, June 9, Heng Rui Pharmaceutical announced that the application for marketing license of subsidiary Emacitinib Sulfate tablets was accepted.